Rejoinder to “Statistical inference problems in sequential parallel comparison designs”-Reference-Cited by-同舟云学术

Rejoinder to “Statistical inference problems in sequential parallel comparison designs”

Published:2019-04-28 Issue:6 Volume:29 Page:1134-1136
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Cui Yifan¹,Ogbagaber Semhar²,Hung H.M. James²

Affiliation:

1. Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, USA

2. Division of Biometric I, Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, Food and Drug Administration, Silver Spring, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543406.2019.1609017

Reference4 articles.

1. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials

2. On clinical trials with a high placebo response rate

3. The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

4. Placebo Response as a Latent Characteristic: Application to Analysis of Sequential Parallel Comparison Design Studies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of the placebo lead-in design for clinical trials with binary outcomes;Clinical Trials;2023-01-10

2. A generalized weighted combination test of treatment effect for clinical trials with a sequential parallel comparison design and binary endpoint;Statistics in Medicine;2022-03-28

3. Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design;Statistics in Medicine;2022-02-20

4. Power calculations for the sequential parallel comparison design with continuous outcomes;Journal of Biopharmaceutical Statistics;2020-09-29